These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1080116)

  • 21. 5-Hydroxytrytophan as an antidepressant. The predictive value of the probenecid test.
    van Praag HM; Korf J
    J Nerv Ment Dis; 1974 May; 158(5):331-7. PubMed ID: 4596091
    [No Abstract]   [Full Text] [Related]  

  • 22. Labelled 5-hydroxytryptamine and 5-hydroxyindoleacetic acid formed in vivo from 3H-tryptophan in rat brain effect of probenecid.
    Schubert J
    Acta Physiol Scand; 1974 Feb; 90(2):401-8. PubMed ID: 4823013
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of the anticonvulsant valproic acid on cerebral indole amine metabolism.
    MacMillan V
    Can J Physiol Pharmacol; 1979 Aug; 57(8):843-7. PubMed ID: 387187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The renal tubular transport and metabolism of serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) in the chicken.
    Hakim R; Watrous WM; Fujimoto JM
    J Pharmacol Exp Ther; 1970 Dec; 175(3):749-62. PubMed ID: 4395226
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of the effects of carbon monoxide intoxication and low-oxygen gas mixtures on cerebral biogenic amine metabolism.
    MacMillan V
    Brain Res; 1987 Apr; 408(1-2):40-6. PubMed ID: 2439173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effects of p-chloroamphetamine and 1-(p-chlorophenyl)piperazine on 5-hydroxyindole concentration in rat brain.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):201-4. PubMed ID: 6157183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotoninergic development in the postnatal rat brain.
    Hedner T; Lundborg P
    J Neural Transm; 1980; 49(4):257-79. PubMed ID: 6162002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of dopa decarboxylation by RO4-4602, MK 485 and MK 486 in human liver homogenates.
    Vogel WH; Mahoney K; Hare TA
    Arch Int Pharmacodyn Ther; 1972; 198(1):85-93. PubMed ID: 4538242
    [No Abstract]   [Full Text] [Related]  

  • 29. An unexpected effect of L-5 hydroxytryptophan-ethyl-ester combined with a peripheral decarboxylase inhibitor on human serum prolactin.
    van Praag HM; Korf J; Lequin RM
    Psychopharmacol Commun; 1976; 2(5-6):369-78. PubMed ID: 1088302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of amitriptyline and isocarboxazid on 5-hydroxytryptophan induced head twitches in mice.
    Nakamura M; Fukushima H; Kitagawa S
    Psychopharmacology (Berl); 1976 Jul; 48(1):101-4. PubMed ID: 823564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabolism of a tryptophan load in rat brain and liver: the influence of L-alpha-methyldopa hydrazine (MK-486, Carbidopa).
    Joseph MH; Hall-Tipping DL
    Biochem Soc Trans; 1978; 6(5):997-1000. PubMed ID: 744365
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa.
    Thal L; Sharpless N; Wolfson L; Engel J; Katzman R
    Trans Am Neurol Assoc; 1976; 101():48-52. PubMed ID: 1088459
    [No Abstract]   [Full Text] [Related]  

  • 33. P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin.
    Sanders-Bush E; Sulser F
    J Pharmacol Exp Ther; 1970 Nov; 175(2):419-26. PubMed ID: 5312363
    [No Abstract]   [Full Text] [Related]  

  • 34. On the tryptophan-serotonin metabolism in manic-depressive disorders. Changes in plasma 5-HT and 5-HIAA levels and urinary 5-HIAA excretion following oral loading of L-5HTP in patients with depression.
    Amamoto T; Sarai K
    Hiroshima J Med Sci; 1976 Sep; 25(2-3):135-40. PubMed ID: 1088369
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of lead and niacin on tryptophan and serotonin metabolism.
    Cupo MA; Donaldson WE
    Drug Nutr Interact; 1988; 5(4):297-308. PubMed ID: 2467790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical assessment of the central 5-HT agonist activity of RU 24969 (a piperidinyl indole).
    Euvrard C; Boissier JR
    Eur J Pharmacol; 1980 Apr; 63(1):65-72. PubMed ID: 6155275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
    Van Woert MH; Sethy VH
    Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The occurrence, synthesis and metabolism of 5-hydroxytryptamine and 5-hydroxytryptophan in the cestode Hymenolepis diminuta: a high performance liquid chromatographic study.
    Ribeiro P; Webb RA
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 79(1):159-64. PubMed ID: 6209062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolerance to the increased locomotor activity produced by L-5-hydroxytryptophan following peripheral decarboxylase inhibition in mice.
    Magyar RL; Gillin JC; Wyatt RJ
    Psychopharmacology (Berl); 1978 Apr; 56(3):343-50. PubMed ID: 418444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of probenecid on 5-hydroxyindoleacetic acid in cisternal cerebrospinal fluid of rats with portacaval anastomosis.
    Bergeron M; Swain MS; Molina-Holgado E; Reader TA; Butterworth RF
    Neurochem Res; 1995 Aug; 20(8):963-7. PubMed ID: 8587655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.